BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 27894261)

  • 21. Kinetics of high-sensitivity cardiac troponin T and I differ in patients with ST-segment elevation myocardial infarction treated by primary coronary intervention.
    Laugaudin G; Kuster N; Petiton A; Leclercq F; Gervasoni R; Macia JC; Cung TT; Dupuy AM; Solecki K; Lattuca B; Cade S; Cransac F; Cristol JP; Roubille F
    Eur Heart J Acute Cardiovasc Care; 2016 Aug; 5(4):354-63. PubMed ID: 25943557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated plasma S100A1 level is a risk factor for ST-segment elevation myocardial infarction and associated with post-infarction cardiac function.
    Fan L; Liu B; Guo R; Luo J; Li H; Li Z; Xu W
    Int J Med Sci; 2019; 16(8):1171-1179. PubMed ID: 31523180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of Infarct Transmurality From C-Reactive Protein Level and Mean Platelet Volume in Patients With ST-Elevation Myocardial Infarction: Comparison of the Predictive Values of Cardiac Enzymes.
    Kim D; Choi DH; Kim BB; Choi SW; Park KH; Song H
    J Clin Lab Anal; 2016 Nov; 30(6):930-940. PubMed ID: 27075615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
    Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
    Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of High-Risk Patients After ST-Segment-Elevation Myocardial Infarction: Comparison Between Angiographic and Magnetic Resonance Parameters.
    Durante A; Laricchia A; Benedetti G; Esposito A; Margonato A; Rimoldi O; De Cobelli F; Colombo A; Camici PG
    Circ Cardiovasc Imaging; 2017 Jun; 10(6):e005841. PubMed ID: 28592591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
    Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
    J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Ndrepepa G; Colleran R; Braun S; Xhepa E; Hieber J; Cassese S; Fusaro M; Kufner S; Laugwitz KL; Schunkert H; Kastrati A
    Catheter Cardiovasc Interv; 2018 Feb; 91(2):215-223. PubMed ID: 28500730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
    Cameron SJ; Sokoll LJ; Laterza OF; Shah S; Green GB
    Clin Chim Acta; 2007 Feb; 376(1-2):168-73. PubMed ID: 17011538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.
    Kopec M; Duma A; Helwani MA; Brown J; Brown F; Gage BF; Gibson DW; Miller JP; Novak E; Jaffe AS; Apple FS; Scott MG; Nagele P
    Anesth Analg; 2017 Feb; 124(2):398-405. PubMed ID: 28002165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction.
    Younger JF; Plein S; Barth J; Ridgway JP; Ball SG; Greenwood JP
    Heart; 2007 Dec; 93(12):1547-51. PubMed ID: 17540686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the longitudinal changes in infarct heterogeneity post myocardial infarction.
    Roifman I; Ghugre NR; Vira T; Zia MI; Zavodni A; Pop M; Connelly KA; Wright GA
    BMC Cardiovasc Disord; 2016 Oct; 16(1):198. PubMed ID: 27741939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With STEMI: A Cardiac Magnetic Resonance Study.
    Pontone G; Andreini D; Guaricci AI; Guglielmo M; Baggiano A; Muscogiuri G; Fusini L; Fazzari F; Berzovini C; Pasquini A; Mushtaq S; Conte E; Cosentino N; Rabbat MG; Marenzi G; Bartorelli AL; Pepi M; Tremoli E; Banfi C
    JACC Cardiovasc Imaging; 2019 Jun; 12(6):1007-1017. PubMed ID: 29680345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late microvascular obstruction after acute myocardial infarction: relation with cardiac and inflammatory markers.
    Mayr A; Klug G; Schocke M; Trieb T; Mair J; Pedarnig K; Pachinger O; Jaschke W; Metzler B
    Int J Cardiol; 2012 Jun; 157(3):391-6. PubMed ID: 21239074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which high-sensitivity troponin variable best characterizes infarct size and microvascular obstruction?
    Schaaf M; Huet F; Akodad M; Gorce-Dupuy AM; Adda J; Macia JC; Delseny D; Leclercq F; Cristol JP; Marin G; Mewton N; Roubille F
    Arch Cardiovasc Dis; 2019 May; 112(5):334-342. PubMed ID: 30777683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction.
    Leibundgut G; Gick M; Morel O; Ferenc M; Werner KD; Comberg T; Kienzle RP; Buettner HJ; Neumann FJ
    Clin Res Cardiol; 2016 May; 105(5):432-40. PubMed ID: 26563201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and Predictive Value of Microvascular Flow Abnormalities after Successful Contemporary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction.
    Aggarwal S; Xie F; High R; Pavlides G; Porter TR
    J Am Soc Echocardiogr; 2018 Jun; 31(6):674-682. PubMed ID: 29525249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction: A Study of the Collaborative Registry on CMR in STEMI.
    Symons R; Pontone G; Schwitter J; Francone M; Iglesias JF; Barison A; Zalewski J; de Luca L; Degrauwe S; Claus P; Guglielmo M; Nessler J; Carbone I; Ferro G; Durak M; Magistrelli P; Lo Presti A; Aquaro GD; Eeckhout E; Roguelov C; Andreini D; Vogt P; Guaricci AI; Mushtaq S; Lorenzoni V; Muller O; Desmet W; Agati L; Janssens S; Bogaert J; Masci PG
    JACC Cardiovasc Imaging; 2018 Jun; 11(6):813-825. PubMed ID: 28823746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?
    Ezekowitz JA; Théroux P; Welsh R; Bata I; Webb J; Armstrong PW
    Can J Physiol Pharmacol; 2007 Jan; 85(1):173-8. PubMed ID: 17487257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.